BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 20137667)

  • 1. [Effects of combining siRNA-TR and TERT upon telomerase activity and in vitro growth inhibition in transitional cancer of bladder BIU-87 cell line].
    Cheng W; Su Y; Ma HQ; Wei ZF; Gao JP; Zhang ZY; Ge JP; Jing KZ; Xu F
    Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(40):2847-52. PubMed ID: 20137667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of combined siRNA-TR and -TERT on telomerase activity and growth of bladder transitional cell cancer BIU-87 cells.
    Cheng W; Wei Z; Gao J; Zhang Z; Ge J; Jing K; Xu F; Xie P
    J Huazhong Univ Sci Technolog Med Sci; 2010 Jun; 30(3):391-6. PubMed ID: 20556588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Construction of adenovirus expressing siRNA against hTR and its anti-tumor activity in vitro].
    Li Y; Xiao LY; Yao G; Li H; Yang ZW; Li WY; Jiang ZH; Li MY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jun; 24(6):570-3. PubMed ID: 18538086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combination of antisense human telomerase RNA and antisense human telomerase catalytic subunit inhibits cervical cancer Hela cells growth].
    Lei LX; Chen ZD
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):42-6. PubMed ID: 15774092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Specific inhibition of hTERT gene expression by short interfering RNAs in gastric cancer SGC7901 cell].
    Ma JP; Zhan WH; Wang JP; Peng JS; Gao JS; Yin QW
    Zhonghua Wai Ke Za Zhi; 2004 Nov; 42(22):1372-6. PubMed ID: 15634407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effective inhibition of hTERT expression by RNA interference on the radiosensitivity of human laryngeal cancer Hep-2 cell line].
    Qiu HB; Zhou YF; Zhou FX; Xie CH; Luo ZG; Yu HJ; Liu SQ
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):9-13. PubMed ID: 17575685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference].
    Zhang PH; Tu ZG; Yang MQ; Huang WF; Zou L; Zhou YL
    Ai Zheng; 2004 Jun; 23(6):619-25. PubMed ID: 15191658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
    Hayashidani Y; Hiyama E; Murakami Y; Sueda T
    Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibitory effect of hTERT dsRNA on telomerase activity in lung carcinoma cell line A549].
    Tian FJ; Wang ZY; Ma JY; Zhao YX; Lu W
    Ai Zheng; 2005 Mar; 24(3):257-61. PubMed ID: 15757523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase inhibition strategies by siRNAs against either hTR or hTERT in oral squamous cell carcinoma.
    Li Y; Li M; Yao G; Geng N; Xie Y; Feng Y; Zhang P; Kong X; Xue J; Cheng S; Zhou J; Xiao L
    Cancer Gene Ther; 2011 May; 18(5):318-25. PubMed ID: 21233858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNAi-hTERT inhibition hepatocellular carcinoma cell proliferation via decreasing telomerase activity.
    Zhang PH; Zou L; Tu ZG
    J Surg Res; 2006 Mar; 131(1):143-9. PubMed ID: 16298398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A DNA vector-based RNAi technology to inhibit the activity of the telomerase of cell line HCCLM3].
    Lu XD; Qin WX; Pan DN; Li JJ; Wan DF; Wen CJ; Li CJ; Gu JR; Yang SL
    Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(16):1381-5. PubMed ID: 15387948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term suppression of telomerase expression in HeLa cell clones, transfected with an expression vector carrying siRNA targeting hTERT mRNA.
    Kurvinen K; Syrjänen S; Johansson B
    Int J Oncol; 2006 Jul; 29(1):279-88. PubMed ID: 16773210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer.
    Takihana Y; Tsuchida T; Fukasawa M; Araki I; Tanabe N; Takeda M
    Int J Urol; 2006 Apr; 13(4):401-8. PubMed ID: 16734859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
    Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
    Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitory effect of antisense human telomerase reverse transcriptase(hTERT) on telomerase activity of human pulmonary giant cell carcinoma cell line(PLA-801D)].
    Ma XB; Han WD; Hao HJ; Li Q; Xu ZM; Lu XC; Zhao YL
    Ai Zheng; 2003 Sep; 22(9):932-7. PubMed ID: 12969524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase in (pre)neoplastic cervical disease.
    Wisman GB; De Jong S; Meersma GJ; Helder MN; Hollema H; de Vries EG; Keith WN; van der Zee AG
    Hum Pathol; 2000 Oct; 31(10):1304-12. PubMed ID: 11070123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The anti-cancer effect of siRNA targeting human telomerase reverse transcriptase in SMMC-7721 cells].
    Zheng SJ; Xia Y; Ren H; Zhong S; Yang Y; Tao P; Wang SQ
    Zhonghua Gan Zang Bing Za Zhi; 2004 Sep; 12(9):530-3. PubMed ID: 15387903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibitory effect of RNAi targeting human telomerase reverse transcriptase against human hepatocellular carcinoma cells].
    Li H; Wang XL; Yang Y; Zhang J; Wang GS; Jiang N; Chen GH
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1323-6. PubMed ID: 18753050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of human telomerase reverse transcriptase through specific activation of RNAi pathway quickly results in cancer cell growth impairment.
    Gandellini P; Folini M; Bandiera R; De Cesare M; Binda M; Veronese S; Daidone MG; Zunino F; Zaffaroni N
    Biochem Pharmacol; 2007 Jun; 73(11):1703-14. PubMed ID: 17321502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.